Back to search
SGLT 2 Inhibitors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SGLT 2 Inhibitors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SGLT 2 Inhibitors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to test the hypothesis that the continuation of empagliflozin during decongestive therapy in the setting of acute decompensat…
While the Fontan operation improves survival for patients with a functional single ventricle, complications like heart failure remain prevalent during follow-up…
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized w…
This is a pharmacokinetic study (PK Study) to better understand empagliflozin dosing in pediatric Duchenne muscular dystrophy patients. Empagliflozin is current…
Participants are being asked to be in a research study. Scientists do research to answer important questions which might help change or improve treatment of par…
In this study, we will test the hypothesis that distinct mechanisms account for the SGLT2i-induced stimulation of ketogenesis and lipolysis versus endogenous (h…
Non-alcoholic fatty liver disease (NAFLD), currently referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is a common hepatic manife…
The goal of this clinical trial is to learn if giving the drug empagliflozin before versus after a heart procedure called primary PCI (percutaneous coronary int…